Tablets — Drug Prices & Cost Comparison
Oral tablet medications. 32 medications tracked with $85.2B in total Medicare spending.
32
Drugs
$85.2B
Medicare Spending
$3,987.75
Avg Cost/Claim
17
Have Generics
Tablets — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Imbruvica | Ibrutinib | $10,445.00 | Yes |
| 2 | Stelara | Ustekinumab | $7,763.00 | Yes |
| 3 | Ozempic | Semaglutide | $685.00 | No |
| 4 | Entresto | Sacubitril/Valsartan | $379.00 | No |
| 5 | Ibrance | Palbociclib | $10,816.00 | Yes |
| 6 | Dupixent | Dupilumab | $2,819.00 | No |
| 7 | Trulicity | Dulaglutide | $473.00 | No |
| 8 | Xtandi | Enzalutamide | $9,331.00 | Yes |
| 9 | Jardiance | Empagliflozin | $210.00 | Yes |
| 10 | Biktarvy | Bictegravir/Emtricitabine/TAF | $3,746.00 | No |
| 11 | Cosentyx | Secukinumab | $3,616.00 | Yes |
| 12 | Farxiga | Dapagliflozin | $266.00 | Yes |
| 13 | Januvia | Sitagliptin | $219.00 | No |
| 14 | Jakafi | Ruxolitinib | $11,432.00 | No |
| 15 | Repatha | Evolocumab | $757.00 | No |
| 16 | Skyrizi | Risankizumab | $4,475.00 | No |
| 17 | Wegovy | Semaglutide (weight) | $820.00 | Yes |
| 18 | Rinvoq | Upadacitinib | $3,498.00 | No |
| 19 | Venclexta | Venetoclax | $6,784.00 | No |
| 20 | Tagrisso | Osimertinib | $11,591.00 | No |
| 21 | Otezla | Apremilast | $1,873.00 | Yes |
| 22 | Nucala | Mepolizumab | $2,720.00 | Yes |
| 23 | Latuda | Lurasidone | $300.00 | Yes |
| 24 | Vyvanse | Lisdexamfetamine | $238.00 | Yes |
| 25 | Aubagio | Teriflunomide | $3,363.00 | Yes |
| 26 | Harvoni | Ledipasvir/Sofosbuvir | $24,958.00 | No |
| 27 | Trintellix | Vortioxetine | $278.00 | No |
| 28 | Fasenra | Benralizumab | $2,836.00 | No |
| 29 | Praluent | Alirocumab | $706.00 | Yes |
| 30 | Levemir | Insulin Detemir | $167.00 | Yes |
| 31 | Crestor | Rosuvastatin | $28.00 | Yes |
| 32 | Lipitor | Atorvastatin | $16.00 | Yes |
Frequently Asked Questions
Medicare Part D tracks 32 tablets with combined spending of $85.2B. The average cost per claim is $3,987.75.
Tablets are generally the most affordable dosage form because they are the easiest and cheapest to manufacture.
All pricing and spending data comes from the CMS Medicare Part D Drug Spending Dashboard. Dosage form classifications come from the FDA Orange Book and drug labels.